These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 18472640
1. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells. Deeb D, Gao X, Dulchavsky SA, Gautam SC. J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640 [Abstract] [Full Text] [Related]
11. ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells. Gao X, Liu Y, Deeb D, Liu P, Liu A, Arbab AS, Gautam SC. Anticancer Res; 2013 Jan; 33(1):215-21. PubMed ID: 23267148 [Abstract] [Full Text] [Related]
12. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Deeb D, Gao X, Liu Y, Jiang D, Divine GW, Arbab AS, Dulchavsky SA, Gautam SC. Carcinogenesis; 2011 May; 32(5):757-64. PubMed ID: 21325633 [Abstract] [Full Text] [Related]
13. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. Shishodia S, Sethi G, Konopleva M, Andreeff M, Aggarwal BB. Clin Cancer Res; 2006 Mar 15; 12(6):1828-38. PubMed ID: 16551868 [Abstract] [Full Text] [Related]
14. Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells. Liu Y, Gao X, Deeb D, Gautam SC. Biochem Biophys Res Commun; 2012 Jan 06; 417(1):570-5. PubMed ID: 22177954 [Abstract] [Full Text] [Related]
15. Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells. Gao X, Deeb D, Hao J, Liu Y, Arbab AS, Dulchavsky SA, Gautam SC. Anticancer Res; 2010 Mar 06; 30(3):785-92. PubMed ID: 20392997 [Abstract] [Full Text] [Related]
16. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer. Liu Y, Gao X, Deeb D, Arbab AS, Gautam SC. Molecules; 2012 Dec 11; 17(12):14795-809. PubMed ID: 23519253 [Abstract] [Full Text] [Related]
17. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells. Estrada AC, Syrovets T, Pitterle K, Lunov O, Büchele B, Schimana-Pfeifer J, Schmidt T, Morad SA, Simmet T. Mol Pharmacol; 2010 Mar 11; 77(3):378-87. PubMed ID: 20018812 [Abstract] [Full Text] [Related]
18. Triterpenoids as new promising anticancer drugs. Petronelli A, Pannitteri G, Testa U. Anticancer Drugs; 2009 Nov 11; 20(10):880-92. PubMed ID: 19745720 [Abstract] [Full Text] [Related]
19. Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer. Gao X, Deeb D, Liu Y, Arbab AS, Divine GW, Dulchavsky SA, Gautam SC. Cancers (Basel); 2011 Nov 11; 3(3):3353-69. PubMed ID: 21961053 [Abstract] [Full Text] [Related]
20. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth. Chen J, Ouyang ZG, Zhang SH, Zhen YS. Oncol Rep; 2007 Jun 11; 17(6):1445-51. PubMed ID: 17487403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]